| 000 | 01904 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515071517.0 | ||
| 264 | 0 | _c20071012 | |
| 008 | 200710s 0 0 eng d | ||
| 022 | _a0268-1161 | ||
| 024 | 7 |
_a10.1093/humrep/dem109 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSimoncini, T | |
| 245 | 0 | 0 |
_aDrospirenone increases endothelial nitric oxide synthesis via a combined action on progesterone and mineralocorticoid receptors. _h[electronic resource] |
| 260 |
_bHuman reproduction (Oxford, England) _cAug 2007 |
||
| 300 |
_a2325-34 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAldosterone _xpharmacology |
| 650 | 0 | 4 |
_aAndrostadienes _xpharmacology |
| 650 | 0 | 4 |
_aAndrostenes _xpharmacology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aEstradiol _xpharmacology |
| 650 | 0 | 4 |
_aFlavonoids _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMedroxyprogesterone Acetate _xpharmacology |
| 650 | 0 | 4 |
_aMifepristone _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide _xbiosynthesis |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xdrug effects |
| 650 | 0 | 4 |
_aProgesterone _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Mineralocorticoid _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Progesterone _xdrug effects |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aWortmannin |
| 700 | 1 | _aFu, X-D | |
| 700 | 1 | _aCaruso, A | |
| 700 | 1 | _aGaribaldi, S | |
| 700 | 1 | _aBaldacci, C | |
| 700 | 1 | _aGiretti, M S | |
| 700 | 1 | _aMannella, P | |
| 700 | 1 | _aFlamini, M I | |
| 700 | 1 | _aSanchez, A M | |
| 700 | 1 | _aGenazzani, A R | |
| 773 | 0 |
_tHuman reproduction (Oxford, England) _gvol. 22 _gno. 8 _gp. 2325-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/humrep/dem109 _zAvailable from publisher's website |
| 999 |
_c17085109 _d17085109 |
||